v3 Template
A
Allegria Therapeutics
Healthcare
Founded
--
Employees
--
Total Funding
$3.5M
Funding Rounds
1
Last Funding
2024-05-06
About Allegria Therapeutics
Allegria Therapeutics is committed to restoring quality of life for people suffering from allergy and inflammatory diseases associated with mast cell dysfunction.
Specialties
Allergy treatment
Inflammatory disease treatment
Mast cell dysfunction
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Seed T: - FT: Seed |
A: 3500000 MR: - FA: 3.5 Million FAN: 3500000 |
D: 2024-05-06 FD: 2024-05-06 |
1 investors |
Seed
Latest
2024-05-06
$3.5M
1 investor (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Allegria Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- allegriatx.com
- Industries
- Healthcare
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro